Näytä suppeat kuvailutiedot

dc.contributor.authorLehti, Maarit
dc.contributor.authorValkeinen, Heli
dc.contributor.authorSipilä, Sarianna
dc.contributor.authorPerhonen, Merja
dc.contributor.authorRottensteiner, Mirva
dc.contributor.authorPullinen, Teemu
dc.contributor.authorPietiläinen, Rauno
dc.contributor.authorNyman, Kai
dc.contributor.authorVehkaoja, Antti
dc.contributor.authorKainulainen, Heikki
dc.contributor.authorKujala, Urho M.
dc.date.accessioned2020-10-09T09:27:55Z
dc.date.available2020-10-09T09:27:55Z
dc.date.issued2020
dc.identifier.citationLehti, M., Valkeinen, H., Sipilä, S., Perhonen, M., Rottensteiner, M., Pullinen, T., Pietiläinen, R., Nyman, K., Vehkaoja, A., Kainulainen, H., & Kujala, U. M. (2020). Effects of aerobic and strength training on aerobic capacity, muscle strength, and gene expression of lymphomonocytes in patients with stable CAD. <i>American Journal of Translational Research</i>, <i>12</i>(8), 4582-4593. <a href="http://www.ajtr.org/files/ajtr0107339.pdf" target="_blank">http://www.ajtr.org/files/ajtr0107339.pdf</a>
dc.identifier.otherCONVID_42414216
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/72088
dc.description.abstractThis study examined the effectiveness, suitability, and safety of a mixed interval-type aerobic and strength training program (MIAST) on physical fitness in patients with stable coronary artery disease (CAD) without history of myocardial infarction (MI). Twenty-three patients with stable CAD were randomly assigned to a MIAST (n = 12; mean age 58.6 years) or control (n = 11; 63.3 years) group. The MIAST group participated in the progressive training program twice a week for 21 weeks. Peak oxygen uptake (VO2peak), workload, and exercise time were measured as were maximal muscle strength, serum lipids, glucose concentration, and the cross-sectional area (CSA) of knee extensors. The safety and suitability of the program were assessed by wireless electrocardiogram (ECG) monitoring and exercise diaries. VO2peak (6.9%; P < 0.05) and exercise time (11.2%; P < 0.05) improved significantly after 12 weeks of training in the MIAST group compared to the control group. Muscle strength (19.9%; P < 0.05) and CSA (2.2%; P < 0.05) increased, and serum lipids and blood glucose tended to decrease after the training. The successful training program (increase in maximal oxygen uptake) increased the gene expression of oxygen metabolism and decreased the gene expression of inflammation pathways in lymphomonocytes. The MIAST program, including interval-type aerobic and strength training, was safe, did not cause any adverse effects, and led to significant improvements in physical fitness in patients with stable CAD.en
dc.format.mimetypeapplication/pdf
dc.languageeng
dc.language.isoeng
dc.publishere-Century Publishing Corporation
dc.relation.ispartofseriesAmerican Journal of Translational Research
dc.relation.urihttp://www.ajtr.org/files/ajtr0107339.pdf
dc.rightsCC BY-NC 4.0
dc.subject.othercoronary heart disease
dc.subject.otherphysical fitness
dc.subject.otheroxygen consumption
dc.subject.otherendurance training
dc.subject.otherresistance training
dc.titleEffects of aerobic and strength training on aerobic capacity, muscle strength, and gene expression of lymphomonocytes in patients with stable CAD
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202010096142
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.contributor.oppiaineGerontologia ja kansanterveysfi
dc.contributor.oppiaineLiikuntalääketiedefi
dc.contributor.oppiaineLiikuntafysiologiafi
dc.contributor.oppiaineGerontology and Public Healthen
dc.contributor.oppiaineSports and Exercise Medicineen
dc.contributor.oppiaineExercise Physiologyen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.format.pagerange4582-4593
dc.relation.issn1943-8141
dc.relation.numberinseries8
dc.relation.volume12
dc.type.versionpublishedVersion
dc.rights.copyright© Authors, 2020
dc.rights.accesslevelopenAccessfi
dc.subject.ysoliikuntahoito
dc.subject.ysosepelvaltimotauti
dc.subject.ysolihasvoima
dc.subject.ysohapenotto
dc.subject.ysovoimaharjoittelu
dc.subject.ysopotilaat
dc.subject.ysokestävyysharjoittelu
dc.subject.ysofyysinen kunto
dc.subject.ysomaksimaalinen hapenotto
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p7811
jyx.subject.urihttp://www.yso.fi/onto/yso/p16060
jyx.subject.urihttp://www.yso.fi/onto/yso/p23362
jyx.subject.urihttp://www.yso.fi/onto/yso/p25455
jyx.subject.urihttp://www.yso.fi/onto/yso/p16233
jyx.subject.urihttp://www.yso.fi/onto/yso/p8357
jyx.subject.urihttp://www.yso.fi/onto/yso/p7676
jyx.subject.urihttp://www.yso.fi/onto/yso/p7384
jyx.subject.urihttp://www.yso.fi/onto/yso/p25454
dc.rights.urlhttps://creativecommons.org/licenses/by-nc/4.0/
jyx.fundinginformationThe study was supported financially by the Ministry of Education of Finland, Foundation for Physical Activity and Public Health LIKES, Finland, and Juho Vainio Foundation, Finland
dc.type.okmA1


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY-NC 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY-NC 4.0